Shanghai Henlius Biotech, Inc. (HKG:2696)
84.10
+1.05 (1.26%)
Apr 17, 2026, 1:25 PM HKT
Shanghai Henlius Biotech Employees
Shanghai Henlius Biotech had 3,762 employees as of December 31, 2025. The number of employees increased by 247 or 7.03% compared to the previous year.
Employees
3,762
Change
247
Growth
7.03%
Revenue / Employee
1.97M HKD
Profits / Employee
244.64K HKD
Market Cap
45.14B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3,762 | 247 | 7.03% |
| Jun 30, 2025 | 3,537 | - | - |
| Dec 31, 2024 | 3,515 | -122 | -3.35% |
| Dec 31, 2023 | 3,637 | 231 | 6.78% |
| Dec 31, 2022 | 3,406 | 1,172 | 52.46% |
| Dec 31, 2021 | 2,234 | 361 | 19.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Genscript Biotech | 6,165 |
| 3SBio | 6,109 |
| RemeGen | 3,048 |
| Shanghai Junshi Biosciences | 2,903 |
| Zai Lab | 1,784 |
| Keymed Biosciences | 1,625 |
| Biocytogen Pharmaceuticals (Beijing) | 1,306 |
| InnoCare Pharma | 1,176 |